These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Access to syringes in three Russian cities: implications for syringe distribution and coverage. Sarang A, Rhodes T, Platt L. Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910 [Abstract] [Full Text] [Related]
5. Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs. Des Jarlais DC, Braine N, Yi H, Turner C. AIDS Educ Prev; 2007 Apr; 19(2):111-23. PubMed ID: 17411414 [Abstract] [Full Text] [Related]
6. New York harm reduction educators. Ruefli T. Newsline People AIDS Coalit N Y; 1998 Jun; ():9-12. PubMed ID: 11367473 [Abstract] [Full Text] [Related]
8. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes. Bruneau J, Daniel M, Kestens Y, Zang G, Généreux M. J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731 [Abstract] [Full Text] [Related]
12. ADAPT: Association for Drug Abuse and Prevention and Treatment. Cintron M. Newsline People AIDS Coalit N Y; 1998 Jun; ():13-7. PubMed ID: 11367467 [Abstract] [Full Text] [Related]
13. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes. Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, Asch SM, Bluthenthal RN. J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466 [Abstract] [Full Text] [Related]
14. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants. Disney E, Kidorf M, Kolodner K, King V, Peirce J, Beilenson P, Brooner RK. J Nerv Ment Dis; 2006 Aug; 194(8):577-83. PubMed ID: 16909065 [Abstract] [Full Text] [Related]
15. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users. Amundsen EJ. Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880 [No Abstract] [Full Text] [Related]
16. New York City injection drug users' memories of syringe-sharing patterns and changes during the peak of the HIV/AIDS epidemic. Rockwell R, Joseph H, Friedman SR. AIDS Behav; 2006 Nov; 10(6):691-8. PubMed ID: 16708274 [Abstract] [Full Text] [Related]
17. Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs. Grau LE, Bluthenthal RN, Marshall P, Singer M, Heimer R. AIDS Behav; 2005 Dec; 9(4):495-504. PubMed ID: 16237501 [Abstract] [Full Text] [Related]
18. Drug use and HIV risk practices of secondary and primary needle exchange users. Huo D, Bailey SL, Hershow RC, Ouellet L. AIDS Educ Prev; 2005 Apr; 17(2):170-84. PubMed ID: 15899754 [Abstract] [Full Text] [Related]
19. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed. Emmanuel F, Fatima M. Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206 [Abstract] [Full Text] [Related]
20. HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs. Braine N, Des Jarlais DC, Goldblatt C, Zadoretzky C, Turner C. AIDS Educ Prev; 2005 Dec; 17(6):515-24. PubMed ID: 16398574 [Abstract] [Full Text] [Related] Page: [Next] [New Search]